Market revenue in 2023 | USD 280.6 million |
Market revenue in 2030 | USD 614.1 million |
Growth rate | 11.8% (CAGR from 2023 to 2030) |
Largest segment | Abdominal aortic aneurysm (aaa) |
Fastest growing segment | Abdominal Aortic Aneurysm (AAA) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Thoracic Aortic Aneurysm (TAA), Abdominal Aortic Aneurysm (AAA) |
Key market players worldwide | W.L. Gore & Associates, Medtronic PLC, MicroPort Scientific Corp, Cook Group, Cryolife, Cardinal Health Inc, Terumo Corp, Endologix, Lombard Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aortic aneurysm market will help companies and investors design strategic landscapes.
Abdominal aortic aneurysm (aaa) was the largest segment with a revenue share of 71.45% in 2023. Horizon Databook has segmented the China aortic aneurysm market based on thoracic aortic aneurysm (taa), abdominal aortic aneurysm (aaa) covering the revenue growth of each sub-segment from 2018 to 2030.
In China, EVAR is mostly performed by surgeons in operating rooms. More than 2,000 cases are performed annually in about 200 regional centers in China. The main centers for endovascular surgery are located mainly in Beijing, Shanghai, and Guangzhou.
In China, the percentage of thoracic endograft implants being performed annually is almost equal to abdominal procedures. It has been estimated that at least 40%–50% of endografts in China are performed for thoracic dissections. EVAR comprises about half of TEVAR numbers in China.
Major factors driving the thoracic aortic aneurysm market in the country are hypertension and smoking. Medtronic's two devices the Valiant and Talent grafts dominate the stent graft market in China, with Cook's Zenith product line as the second largest shareholder. There are a number of local players in the market that comprise about half of the total market of stent grafts.
Horizon Databook provides a detailed overview of country-level data and insights on the China aortic aneurysm market , including forecasts for subscribers. This country databook contains high-level insights into China aortic aneurysm market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account